However, the number of individuals examined in this study was relatively small, and additional studies with more patients are needed to verify the effects of EZH2 polymorphisms on HCC that we observed and to explore the effects of these variants on the biological function of EZH2. This evidence concerns the gene EZH2 and hepatocellular carcinoma.